Evidence map›Paper›PMID 38912685›Full record

ArticleJournal of addiction medicine

Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants.

Katherine S Elkington, Margaret E Ryan, Cale Basaraba, Renald Dambreville, Dan Alschuler, Melanie M Wall, Alejandra Garcia, Monica Christofferson, Howard F Andrews, Edward V Nunes

Abstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katherine S ElkingtonFrom the Center for Behavioral Health and Youth Justice, Division of Child and Adolescent Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY (KSE, MER); Mental Health Data Science, New York Psychiatric Institute, New York, NY (CB, RD, DA); Department of Psychiatry, Columbia University, New York, NY (KSE, MER, CB, RD, DA, MMW); Mental Health Data Science, Columbia University and New York Psychiatric Institute, New York, NY (MMW); Center for Justice Innovation, New York, NY (AG, MC); Data Coordinating Center, Columbia University and New York State Psychiatric Institute, New York, NY (HFA); and Division on Substance Use Disorders, Columbia University and New York State Psychiatric Institute, New York, NY (EVN).ORCID 0000-0002-0562-0802
Margaret E Ryan
Cale Basaraba
Renald Dambreville
Dan Alschuler
Melanie M Wall
Alejandra Garcia
Monica Christofferson
Howard F Andrews
Edward V Nunes

Funding

Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment ApproachesUG1DA050071 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ELKINGTON, KATHERINE S, NUNES, EDWARD V. · 2019 to 2023
$9.5M
NIDA NIH HHS UG1 DA050071
6 · The paper itself

Abstract

objectiveThe opioid intervention court (OIC) is an innovative, pre-plea treatment court to facilitate rapid linkage to medications for opioid use disorder (MOUD) for people at risk of overdose. This study compares participants in OIC and participants with opioid use problems in a traditional drug treatment court model on (i) initiation for any substance use (SU) treatment, (ii) initiation of MOUD, (iii) number of days to MOUD initiation, and (iv) retention in the OIC program/retention on MOUD.

methodsWe used administrative court records from n = 389 OIC and n = 229 drug court participants in 2 counties in New York State. Differences in outcomes by court were assessed using logistic, multinomial, or linear regressions.

resultsAfter adjusting for current charge severity, gender, race/ethnicity, age, and county, OIC participants were no more likely to initiate any SU treatment but were significantly more likely to initiate MOUD (81.2% OIC vs 45.9% drug court, P < 0.001) and were more quickly linked to any SU treatment (hazard ratio = 1.68, 95% confidence interval = 1.35-2.08) and MOUD (hazard ratio = 4.25, 95% confidence interval = 3.23-5.58) after starting the court. Retention in court/MOUD was higher among drug court participants and may speak to the immediate sanctions (eg, jail) for noncompliance with drug court directives as compared with opioid court, which does not carry such immediate sanctions for noncompliance.

conclusionsThese analyses suggest that the new OIC model can more rapidly link participants to treatment, including MOUD, as compared with traditional drug court model, and may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants.

Indexed as

Opioid-Related DisordersAdultFemaleHealth Services AccessibilityHumansMaleMiddle AgedNew YorkOpiate Substitution TreatmentYoung Adult

Identifiers

PMID38912685
PMCPMC11537812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.